: , , BPC-157
Funding acquisition, WL, YYZ, and ML
No human studies of BPC-157 for neuroprotection have been published
It distinguishes the product as a combination formulation rather than a single agent, relevant for researchers comparing single-compound vs multi-compound experimental approaches
Dr John Batsis, a professor of medicine at the University of North Carolina at Chapel Hill, told Newsweek that he also agreed with the list, and said that he would also add "eggs, cottage cheese, Greek yogurt, milk or fortified soy milk, fish, poultry, lean meats, beans and nut butters." "The best choices will depend on dietary preferences, medical conditions and gastrointestinal tolerance
Its used extensively in injections due to its long-acting nature and is often the preferred form for treating severe B12 deficiencies